All exams GARBI ESI
In one line
The Government of India approved the Biovigilance Programme of India, to strengthen safety monitoring of medicines and biological products used in organ and tissue transplantation.
Context
What It Is
Free live session
NABARD Sprint 60: the 2025 cut-offs and your 60-day Phase I plan
Today · 7:30 PM IST
- A national patient-safety surveillance programme
- For the systematic reporting, assessment, monitoring and prevention of adverse events associated with medicines and biological products used in transplantation
- Coordinated by the Indian Pharmacopoeia Commission (IPC)
